Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction

Biochemical and Biophysical Research Communications

Volumn 372, Issue 3, 2008, Pages 440-446

  Barakat, Stéphane ^a,b   Turcotte, Sandra ^a   Demeule, Michel ^c   Lachambre, Marie Paule ^a   Régina, Anthony ^a   Baggetto, Loris G ^b   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c ANGIOCHEM INC   (Canada)

Author keywords

Blood brain barrier; Caveolae; Caveolin 1; Endothelial cells; Migration; P glycoprotein; Tubulogenesis

Indexed keywords

CAVEOLIN 1; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL STIMULATION; DOWN REGULATION; ENDOTHELIUM CELL; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; BRAIN; CAVEOLIN 1; CELL LINE; CELL MOVEMENT; CYCLOSPORINE; CYCLOSPORINS; DOGS; ENDOTHELIAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; P-GLYCOPROTEIN; RATS; RNA, SMALL INTERFERING;

RATTUS;

EID: 44749088919     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.012     Document Type: Article

References (25)

1. Juliano R.L. The role of drug delivery systems in cancer chemotherapy. Prog. Clin. Biol. Res 9 (1976) 21-32
2. Demeule M., Regina A., Jodoin J., Laplante A., Dagenais C., Berthelet F., Moghrabi A., and Beliveau R. Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier. Vascul. Pharmacol. 38 (2002) 339-348
3. Jonker J.W., Wagenaar E., van Deemter L., Gottschlich R., Bender H.M., Dasenbrock J., and Schinkel A.H. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgesic drug. Br. J. Pharmacol. 127 (1999) 43-50
4. Johnstone R.W., Ruefli A.A., and Smyth M.J. Multiple physiological functions for multidrug transporter P-glycoprotein?. Trends. Biochem. Sci. 25 (2000) 1-6
5. Debry P., Nash E.A., Neklason D.W., and Metherall J.E. Role of multidrug resistance P-glycoproteins in cholesterol esterification. J. Biol. Chem. 272 (1997) 1026-1031
6. van Helvoort A., Giudici M.L., Thielemans M., and van Meer G. Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J. Cell Sci. 110 Pt 1 (1997) 75-83
7. Lavie Y., Fiucci G., Czarny M., and Liscovitch M. Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells. Lipids 34 Suppl (1999) S57-S63
8. Demeule M., Jodoin J., Gingras D., and Beliveau R. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett. 466 (2000) 219-224
9. Jodoin J., Demeule M., Fenart L., Cecchelli R., Farmer S., Linton K.J., Higgins C.F., and Beliveau R. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. J. Neurochem. 87 (2003) 1010-1023
10. Hinrichs J.W., Klappe K., Hummel I., and Kok J.W. ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells. J. Biol. Chem. 279 (2004) 5734-5738
11. Radeva G., Perabo J., and Sharom F.J. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains. FEBS J. 272 (2005) 4924-4937
12. Gaus K., Rodriguez M., Ruberu K.R., Gelissen I., Sloane T.M., Kritharides L., and Jessup W. Domain-specific lipid distribution in macrophage plasma membranes. J. Lipid. Res. 46 (2005) 1526-1538
13. Randolph G.J., Beaulieu S., Pope M., Sugawara I., Hoffman L., Steinman R.M., and Muller W.A. A physiologic function for P-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. USA 95 (1998) 6924-6929
14. Miletti-Gonzalez K.E., Chen S., Muthukumaran N., Saglimbeni G.N., Wu X., Yang J., Apolito K., Shih W.J., Hait W.N., and Rodriguez-Rodriguez L. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 65 (2005) 6660-6667
15. Dupree P., Parton R.G., Raposo G., Kurzchalia T.V., and Simons K. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12 (1993) 1597-1605
16. Cohen A.W., Razani B., Wang X.B., Combs T.P., Williams T.M., Scherer P.E., and Lisanti M.P. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am. J. Physiol. Cell. Physiol. 285 (2003) C222-C235
17. Uittenbogaard A., and Smart E.J. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. J. Biol. Chem. 275 (2000) 25595-25599
18. Volonte D., Liu Y., and Galbiati F. The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J. 19 (2005) 237-239
19. Roux F., Durieu-Trautmann O., Bourre J.M., Strosberg A.D., and Couraud P.O. Immortalized rat brain microvessel endothelial cells: I-expression of blood-brain barrier markers during angiogenesis. Adv. Exp. Med. Biol. 331 (1993) 201-204
20. Muller W., Saeger W., Wellhausen L., Derwahl K.M., Hamacher C., and Ludecke D.K. Markers of function and proliferation in non-invasive and invasive bi- and plurihormonal adenomas of patients with acromegaly: an immunohistochemical study. Pathol. Res. Pract. 195 (1999) 595-603
21. Mochida Y., Taguchi K., Taniguchi S., Tsuneyoshi M., Kuwano H., Tsuzuki T., Kuwano M., and Wada M. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis 24 (2003) 1219-1224
22. Maupas-Schwalm F., Auge N., Robinet C., Cambus J.P., Parsons S.J., Salvayre R., and Negre-Salvayre A. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J. 18 (2004) 1398-1400
23. Raggers R.J., Vogels I., and van Meer G. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem. J. 357 (2001) 859-865
24. Fujita Y., Maruyama S., Kogo H., Matsuo S., and Fujimoto T. Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int. 66 (2004) 1794-1804
25. Navarro A., Anand-Apte B., and Parat M.O. A role for caveolae in cell migration. FASEB J. 18 (2004) 1801-1811